Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Terminated 5Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Melanoma 5Leukemia 5Prostatic Neoplasms 3Lymphoma 3Sarcoma 2Ovarian Neoplasms 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Congenital Abnormalities 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Myelodysplastic Syndromes 1

Interventions

Fluorouracil 34Leucovorin 31Oxaliplatin 25Irinotecan 19Capecitabine 13Folfox protocol 11Chemotherapy, Adjuvant 11Cetuximab 11Bevacizumab 9Neoadjuvant Therapy 8XELOX 7Laparoscopy 7Drug Therapy 7Endoscopic Mucosal Resection 5Colonoscopy 5Surgical Procedures, Operative 4Gemcitabine 4Tegafur 3Radiotherapy 3Propofol 3Preoperative Exercise 3Panitumumab 3Fentanyl 3Curcumin 3Colectomy 3Celecoxib 3Aspirin 3raltitrexed 2Surveys and Questionnaires 2Sodium Chloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colonic Neoplasms × Gene Expression Profiling × Clear all
NCT00884767 2009-07-08

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

National Cancer Institute (NCI)

Phase 2 Unknown
206 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡